Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA522061
Max Phase: Preclinical
Molecular Formula: C23H18O3
Molecular Weight: 342.39
Molecule Type: Small molecule
Associated Items:
ID: ALA522061
Max Phase: Preclinical
Molecular Formula: C23H18O3
Molecular Weight: 342.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2oc(-c3cc(Cc4ccccc4)ccc3O)cc(=O)c2c1
Standard InChI: InChI=1S/C23H18O3/c1-15-7-10-22-18(11-15)21(25)14-23(26-22)19-13-17(8-9-20(19)24)12-16-5-3-2-4-6-16/h2-11,13-14,24H,12H2,1H3
Standard InChI Key: UHHVZGAPCPFAGJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 342.39 | Molecular Weight (Monoisotopic): 342.1256 | AlogP: 5.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.41 | CX Basic pKa: | CX LogP: 5.27 | CX LogD: 5.23 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.57 | Np Likeness Score: 0.39 |
1. Nilsson J, Nielsen EØ, Liljefors T, Nielsen M, Sterner O.. (2008) Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors., 18 (21): [PMID:18851913] [10.1016/j.bmcl.2008.09.092] |
Source(1):